chartexchange

IKT
Inhibikase Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 19, 2026 3:59:55 PM EST
1.30USD-5.435%(-0.08)495,647
After-hoursNov 19, 2026 4:00:30 PM EST
1.30USD-0.383%(-0.00)
1.0700Bid1.5400Ask0.4700Spread

IKT Financials

In Q3 FY 2026 (ended ), Inhibikase Therapeutics, Inc. Common Stock (IKT) reported net income of −$20.47M, operating cash flow of −$17.35M, and assets of $201.75M (filed ).

Loading financial statements…